In the last decade, GH therapy has yielded favorable results for childhood growth disorders and adult GHD; however, little is known about the particular functions in the hematopoietic system of GHD patients, including apoptosis, in course of GH therapy. This evidence concerns the gene GH1 and hereditary endocrine growth disease.